Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial.

MLA

Lewis, Richard A., et al. “Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial.” American Journal of Ophthalmology, vol. 175, Mar. 2017, pp. 137–47. EBSCOhost, https://doi.org/10.1016/j.ajo.2016.11.020.

APA

Lewis, R. A., Christie, W. C., Day, D. G., Craven, E. R., Walters, T., Bejanian, M., Lee, S. S., Goodkin, M. L., Zhang, J., Whitcup, S. M., & Robinson, M. R. (2017). Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial. American Journal of Ophthalmology, 175, 137–147. https://doi.org/10.1016/j.ajo.2016.11.020

Chicago

Lewis, Richard A, William C Christie, Douglas G Day, E Randy Craven, Thomas Walters, Marina Bejanian, Susan S Lee, et al. 2017. “Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial.” American Journal of Ophthalmology 175 (March): 137–47. doi:10.1016/j.ajo.2016.11.020.